Prevacid 24HR delayed-release capsules recalled over manufacturing violations
- Recall date
- September 26, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- GLAXOSMITHKLINE NEBRASKA recalls Prevacid 24HR (Lansoprazole) delayed-release capsules, 15 mg, 14 capsules per bottle in a carton containing 1 bottle (N…
- Recall number
- D-0088-2019
- FDA classification
- Class II
- Brand / firm
- GLAXOSMITHKLINE NEBRASKA
- Sold / distributed
- Nationwide USA and Puerto Rico
Why it was recalled
CGMP deviations
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Prevacid 24HR (Lansoprazole) delayed-release capsules, 15 mg, 14 capsules per bottle in a carton containing 1 bottle (NDC: 0067-6286-14), 2 bottles (NDC: 0067-6286-28) or 3 bottles (NDC: 0067-6286-42), Over-the-counter, Distributed By: GSK Consumer Healthcare, Warren, NJ 07059.
Get recall alerts
Free email alert whenever GLAXOSMITHKLINE NEBRASKA has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: GLAXOSMITHKLINE NEBRASKA